Worasith, Chanika
Sithithaworn, Jiraporn
Wongphutorn, Phattharaphon
Homwong, Chutima
Khongsukwiwat, Kanoknan
Techasen, Anchalee
Kopolrat, Kulthida Y.
Loilome, Watcharin
Namwat, Nisana
Thinkamrop, Bandit
Tawarungruang, Chaiwat
Titapun, Attapol
Laha, Thewarach
Andrews, Ross H.
Taylor-Robinson, Simon D.
Sithithaworn, Paiboon http://orcid.org/0000-0002-9480-1778
Funding for this research was provided by:
National Research Council of Thailand
Post Doctoral Training Program from Khon Kaen University (PD2565-02-01)
Thailand Center of Excellence for Life Sciences
Wellcome Trust ISSF grant
Article History
Received: 14 August 2023
Accepted: 15 November 2023
First Online: 21 November 2023
Declarations
:
: Human subject protocols in this study were approved by the Human Ethics Committee of Khon Kaen University, Thailand (HE631572) and conformed to the precepts of the Declaration of Helsinki on Human Rights (1975). All recruited participants submitted prior written, informed consent. The experimental protocols for laboratory animal handling for the development of a specific monoclonal antibody to <i>Opisthorchis viverrini</i> for diagnostic purposes were approved by the Institutional Animal Ethical Committee, Khon Kaen University (IACUC-KKU-69/64).
: A written, informed consent to share and disseminate data was obtained from all study participants before enrolment. For children aged below 18 years, the consent was obtained from their parent or legal guardian.
: The authors declare that they have no competing interests.